The 62 references in paper S. Avdeev N., K. Popova A., G. Nekludova V., A. Chuchalin G., С. Авдеев Н., К. Попова А., Г. Неклюдова В., А. Чучалин Г. (2014) “ВОЗМОЖНОСТЬ ИСПОЛЬЗОВАНИЯ НЕИНВАЗИВНОЙ ВЕНТИЛЯЦИИ ЛЕГКИХ ПРИ ДЕКОМПЕНСАЦИИ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ // POTENTIAL FOR USE OF NON INVASIVE LUNG VENTILATION IN PATIENTS WITH DECOMPENSATED CHRONIC HEART FAILURE” / spz:neicon:pulmonology:y:2011:i:2:p:41-48

1
Мареев В.Ю., Агеев Ф.Т., Арутюнов Г.П. и др.(от Общества специалистов по СН и секции по СН ВНОК). Национальные рекомендации ВНОК И ОССН по диагностике и лечению ХСН (3-й пересмотр). Сердеч. недостат. 2010; 11 (1): 3–62.
(check this in PDF content)
2
Агеев Ф.Т., Даниелян М.О., Мареев В.Ю. и др. Больные с хронической сердечной недостаточностью в российской амбулаторной практике: особенности контингента, диагностики и лечения (по материалам исследования ЭПОХА-О-ХСН). Сердеч. недостат. 2004; 5 (1): 4–7.
(check this in PDF content)
3
Беленков Ю.Н., Мареев В.Ю. Агеев Ф.Т., Даниелян М.О. Эпидемиологическое обследование больных ХСН в реальной практике (по обращаемости) ЭПОХА-О-ХСН. От имени рабочей группы "Общества специалистов по сердечной недостаточности". Сердеч. недостат. 2003;
(check this in PDF content)
4
3): 116–120. 4.McCullough P.A., Philbin E.F., Spertus J.A. et al. Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J. Am. Coll. Cardiol. 2002; 39: 60–69.
(check this in PDF content)
5
Redfield M.M. Heart failure – an epidemic of uncertain proportions. N. Engl. J. Med. 2002; 347: 1442–1444. Таблица 4 Исследования, посвященные влиянию НВЛ на ФВ ИсследованиеnПациентыРежим НВЛФВ ЛЖ (до), %ФВ ЛЖ (после), % S.Mallone et al., 1991 [42]–ХСН + СОАСCPAP (4 нед., ночью)3749 M.T.Naughton et al., 1995 [30]15ХСН + СОАС + СЦАСCPAP 5–7,5–10 cм вод. ст.(3 мес.)Увеличение на 8 % G.N.Willson et al.,1998 [43]11ХСН + СЦАСVACV / PEEP (3 мес., ночью)2531 B.Acosta et al., 2000 [44]14ХСНBiPAP 5 / 3 см вод. ст. (1 ч)28,734,4 D.D.Sin et al., 2000 [45]66ХСН + СЦАСCPAP 10–12 см вод. ст. (3 мес., ночью)Увеличение на 5,6 % A.Bellone et al., 2002 [41]10ХСНCPAP 10 см вод. ст. vs18,8 и 18,723,6 и 22,8 BiPAP 15 / 5 см вод. ст. (30 мин) D.R.Mansfield et al., 2004 [46]55ХСН + СОАС CPAP 8,8 см вод. ст.3843
(check this in PDF content)
6
Даниелян М.О. Прогноз и лечение хронической сердечной недостаточности (данные 20-летнего наблюдения). Автореф. дис. ... канд. мед. наук. М.; 2001.
(check this in PDF content)
7
Lepage S.Acute decompensated heart failure. Can. J. Cardiol. 2008; 24 (Suppl. B): 6B–8B.
(check this in PDF content)
8
O'Connell J.B., Bristow M.R.Economic impact of heart failure in the United States: Time for a different approach. J. Heart Lung. Transplant 1994; 13: S104–S112.
(check this in PDF content)
9
Cleland J.G., Swedberg K., Follath F. et al.The EuroHeart Failure survey programme a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur. Heart J. 2003; 24: 442–463.
(check this in PDF content)
10
Binanay C., Califf R.M., Hasselblad V. et al. ESCAPE Investigators and ESCAPE Study Coordinators. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. J.A.M.A. 2005; 294: 1625–1633.
(check this in PDF content)
11
Cuffe M.S., Califf R.M., Adams K.F. Jr. et al. Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Investigators. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. J.A.M.A. 2002; 287: 1541–1547.
(check this in PDF content)
12
Fonarow G.C., Adams Jr. K.F., Abraham W.T. et al.Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. J.A.M.A. 2005; 293: 572–580.
(check this in PDF content)
13
Gheorghiade M., Abraham W.T., Albert N.M. et al.Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. J.A.M.A. 2006; 296: 2217–2226.
(check this in PDF content)
14
Komajda M., Follath F., Swedberg K. et al. The EuroHeart Failure Survey programme – a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur. Heart J. 2003; 24: 464–474.
(check this in PDF content)
15
Nieminen M.S., Brutsaert D., Dickstein K. et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur. Heart J. 2006; 27: 2725–36.
(check this in PDF content)
16
Bergh C.*H., Andersson B., Dahlstrom U. et al.Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers. Eur. J. Heart Fail. 2010; 12: 404–410.
(check this in PDF content)
17
Howlett J.G.Current treatment options for early management in acute decompensated heart failure. Can. J. Cardiol. 2008; 24 (Suppl. B): 9B–14B.
(check this in PDF content)
18
Joseph S.M., Cedars A.M., Ewald G.A. et al.Acute decompensated heart failure: contemporary medical management. Tex. Heart Inst. J. 2009; 36: 510–520.
(check this in PDF content)
19
Chatterjee K. Refractory heart failure – drugs and devices. Eur. Heart J. 2001; 22: 2227–2230.
(check this in PDF content)
20
Chan C.T.A critical look at acute decompensated heart failure from a nephrologist's perspective. Nephrol. Dial. Transplant 2009; 24: 2024–2026.
(check this in PDF content)
21
Mehta S., Hill N.S.Noninvasive ventilation. Am. J. Respir. Crit. Care Med. 2001; 163: 540–577.
(check this in PDF content)
22
Barach A.L., Martin J., Eckman M.Positive pressure respiration and its application to the treatment of acute pulmonary edema and respiratory obstruction. Proc. Am. Soc. Clin. Invest. 1937; 16: 664–680.
(check this in PDF content)
23
Poulton E.P., Oxon D.M. Left-sided heart failure with pulmonary oedema: Its treatment with the "pulmonary plus pressure machine." Lancet 1936; 231: 981–983.
(check this in PDF content)
24
Rasanen J., Heikkila J., Downs J. et al. Continuous positive airway pressure by face mask in acute cardiogenic pulmonary edema. Am. J. Cardiol. 1985; 55: 296–300.
(check this in PDF content)
25
Masip J., Roque M., Sanchez B. et al.Noninvasive ventilation in acute cardiogenic pulmonary edema. Systematic review and meta-analysis. J.A.M.A. 2005; 294: 3124–3130.
(check this in PDF content)
26
Pang D., Keenan S.P., Cook D.J., Sibbald W.J. The effect of positive pressure airway support on mortality and the need for intubation incardiogenic pulmonary edema: a systematic review. Chest 1998; 114: 1185–1192.
(check this in PDF content)
27
Peters J.Mechanical ventilation with PEEP – a unique therapy for failing hearts. Intensive Care Med. 1999; 25: 778–780.
(check this in PDF content)
28
Bradley T.D., Logan A.G., Kimoff R.J. et al. Continuous positive airway pressure for central sleep apnea and heart failure. N. Engl. J. Med. 2005; 353: 2025–2033.
(check this in PDF content)
29
Kaneko Y., Floras J.S., Usui K. et al.Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N. Engl. J. Med. 2003; 348: 1233–1241.
(check this in PDF content)
30
Naughton M.T., Rahman M.A., Hara K. et al. Effect of continuous positive airway pressure on intrathoracic and left ventricular transmural pressures in patients with congestive heart failure. Circulation 1995; 91: 1725–1731.
(check this in PDF content)
31
Tkacova R., Hall M.J., Liu P.P. et al.Left ventricular volume in patients with heart failure and Cheyne-Stokes respiration during sleep. Am. J. Respir. Crit. Care Med. 1997; 156: 1549–1555.
(check this in PDF content)
32
Kaye D.M., Mansfield D., Aggarwal A. et al. Acute effects of continuous positive airway pressure on cardiac sympathetic tone in congestive heart failure. Circulation 2001; 103: 2336–2338.
(check this in PDF content)
33
Spaak J., Egri Z.J., Kubo T. et al.Muscle sympathetic nerve activity during wakefulness in heart failure patients with and without sleep apnea. Hypertension 2005; 46: 1327–1332.
(check this in PDF content)
34
Chen Y., Chen P., Hanaoka M. et al.Mechanical ventilation in patients with hypoxemia due to refractory heart failure. Intern. Med. 2008; 47: 367–373.
(check this in PDF content)
35
Диагностика и лечение острой сердечной недостаточности. Российские рекомендации. http://www.cardiosite.ru/ medical/recom*dia.asp
(check this in PDF content)
36
Dickstein K., Cohen*Solal A., Filippatos G. et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur. Heart J. 2008; 29: 2388–2442.
(check this in PDF content)
37
Jessup M., Abraham W.T., Casey D.E. et al.2009 focused update: ACCF / AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation / American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009; 119: 1977–2016.
(check this in PDF content)
38
Borg G.A.Psychophysical basis of perceived exertion. Med. Sci. Sports Exerc. 1982; 14: 377–381.
(check this in PDF content)
39
Black L., Hyatt R. Maximal respiratory pressures: normal values and relationship to age and sex. Am. Rev. Respir. Dis. 1969; 99: 696–702.
(check this in PDF content)
40
Cournand A., Motley H.L., Richards D.W. Physiological studies of the effects of intermittent positive pressure breathing on cardiac output in man. Am. J. Physiol. 1948; 152: 162–174.
(check this in PDF content)
41
Bellone A., Barbieri A., Ricci C. et al.Acute effects of noninvasive ventilatory support on functional mitral regurgitation in patients with exacerbation of congestive heart failure. Intensive Care Med. 2002; 28: 1348–1350.
(check this in PDF content)
42
Malone S., Liu P.P., Holloway R. et al. Obstructive sleep apnoea in patients with dilated cardiomyopathy: effects of continuous positive airway pressure. Lancet 1991; 338: 1480–1484.
(check this in PDF content)
43
Willson G.N., Wilcox I., Piper A.J. et al. Treatment of central sleep apnoea in congestive heart failure with nasal ventilation. Thorax 1998; 53 (Suppl. 3): S41–S46.
(check this in PDF content)
44
Acosta B., DiBenedetto R., Rahimi A. et al.Hemodynamic effects of noninvasive bi-level positive airway pressure on patients with chronic congestive heart failure with systolic dysfunction. Chest 2000; 118: 1004–1009.
(check this in PDF content)
45
Sin D.D., Logan A.G., Fitzgerald F.S. et al.Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation 2000; 102: 61–66.
(check this in PDF content)
46
Mansfield D.R., Gollogly N.C., Kaye D.M. et al. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am. J. Respir. Crit. Care Med. 2004; 169: 361–366.
(check this in PDF content)
47
Arzt M., Schulz M., Wensel R. et al. Nocturnal continuous positive airway pressure improves ventilatory efficiency during exercise in patients with chronic heart failure. Chest 2005; 127: 794–802.
(check this in PDF content)
48
Bendjelid K., Schutz N., Suter P.M. et al.Does continuous positive airway pressure by face mask improve patients with acute cardiogenic pulmonary edema due to left ventricular diastolic dysfunction? Chest 2005; 127: 1053–1058.
(check this in PDF content)
49
Noda A., Izawa H., Asano H. et al.Beneficial effect of bilevel positive airway pressure on left ventricular function in ambulatory patients with idiopathic dilated cardiomyopathy and central sleep apnea-hypopnea. A preliminary study. Chest 2007; 131: 1694–1701.
(check this in PDF content)
50
Khayat R.N., Abraham W.T., Patt B. et al. Cardiac effects of continuous and bi-level positive airway pressure for patients with heart failure and obstructive sleep apnea. A pilot study. Chest 2008; 134: 1162–1168.
(check this in PDF content)
51
Keren G., Katz S., Sonnenblick E.H., LeJemtel T.H. Dynamic mitral regurgitation. An important determinant of the hemodynamic response to load alterations and inotropic therapy in severe heart failure. Circulation 1989; 80: 306–313.
(check this in PDF content)
52
Bellone A., Etteri M., Vettorello M. et al. The effects of continuous positive airway pressure on plasma brain natriuretic peptide concentrations in patients presenting with acute cardiogenic pulmonary edema with preserved left ventricular systolic function. Am. J. Emerg. Med. 2010; 28: 230–234.
(check this in PDF content)
53
Hosenpud J.D., Stibolt T.A., Atwal K. et al.Abnormal pulmonary function specifically related to congestive heart failure: comparison of patients before and after cardiac transplantation. Am. J. Med. 1990; 88: 493–496.
(check this in PDF content)
54
Wittmer V.L., Simoes G.M.S., Sogame L.C.M., Vasquez E.C. Effects of continuous positive airway pressure on pulmonary function and exercise tolerance in patients with congestive heart failure. Chest 2006; 130: 157–163.
(check this in PDF content)
55
Guazzi M., Marenzi G., Alimento M. et al. Improvement of alveolar-capillary membrane diffusing capacity with enalapril in chronic heart failure and counteracting effect of aspirin. Circulation 1997; 95: 1930–1936.
(check this in PDF content)
56
Ambrosino N., Opasich C., Crotti P. et al. Breathing pattern, ventilatory drive and respiratory muscle strength in patients with chronic heart failure. Eur. Respir. J. 1994; 7: 17–22.
(check this in PDF content)
57
Hammond M.D., Bauer K.A., Sharp J.T., Rocha R.D. Respiratory muscle strength in congestive heart failure. Chest 1990; 98: 1091–1094.
(check this in PDF content)
58
Braunwald E. Biomarkers in heart failure. N. Engl. J. Med. 2008; 358: 2148–2159.
(check this in PDF content)
59
Villacorta H., Masetto A.C., Mesquita E.T. C-Reactive protein: an inflammatory marker with prognostic value in patients with decompensated heart failure. Arq. Bras. Cardiol. 2007; 88: 520–523.
(check this in PDF content)
60
Kelly C.A., Newby D.E., McDonagh T.A. et al. Randomised controlled trial of continuous positive airway pressure and standard oxygen therapy in acute pulmonary oedema. Effects on plasma brain natriuretic peptide concentrations. Eur. Heart J. 2002; 23: 1379–1386.
(check this in PDF content)
61
Krauser D., Donald L., Claudia U. et al. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a Pro-BNP investigation of dysphea in the emergency department (PRIDE) substudy. Am. Heart J. 2005; 149: 44–50.
(check this in PDF content)
62
Dohi T., Kasai T., Narui K. et al. Bi-level positive airway pressure ventilation for treating heart failure with central sleep apnea that is unresponsive to continuous positive airway pressure. Circ. J. 2008; 72: 1100–1105. Сведения об авторах
(check this in PDF content)